<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>NeLM - Anaesthesia via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'NeLM - Anaesthesia' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=NeLM+-+Anaesthesia&t=NeLM+-+Anaesthesia&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 28 Mar 2010 13:42:10 +0100</lastBuildDate>
        <item>
            <title>Neuraxial anaesthesia for lower-limb revascularization</title>
            <link>http://www.medworm.com/index.php?rid=3209498&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDisease-Focused-Reviews%2FNeuraxial-anaesthesia-for-lower-limb-revascularization%2F</link>
            <description>Source: Cochrane Library
Area: Evidence &gt; Disease Focused Reviews
 Background 
  Lower-limb revascularization surgery is used to reduce pain and sometimes to improve lower-limb function. The type of anaesthesia used during lower-limb revascularization may affect the risks of both good and bad outcomes. 
 &amp;nbsp; 
  Objectives 
  To determine the rates of death and major complications with spinal and epidural anaesthesia compared with other types of anaesthesia for lower-limb revascularization. 
 &amp;nbsp; 
  Search strategy 
  We searched CENTRAL (The Cochrane Library 2008, Issue 2); MEDLINE (1960 to 10th June 2008); EMBASE (1982 to 10th June 2008); LILACS (1982 to 10th June 2008); CINAHL (1982 to 10th June 2008) and ISI Web of Science (1900 to 10th June 2008). 
 &amp;nbsp; 
  Selection criteria 
...</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3209498</comments>
            <pubDate>Wed, 27 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3209498</guid>        </item>
        <item>
            <title>BOC communication: effects of low external temperatures on medical gases</title>
            <link>http://www.medworm.com/index.php?rid=3154153&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2010---January%2F08%2FBOC-communication-effects-of-low-external-temperatures-on-medical-gases%2F</link>
            <description>Source: BOC Healthcare
Area: News
 In view of the current weather conditions, BOC has issued the following reminder about the effects of low external temperatures on medical gases: 
 &amp;nbsp; 
 Entonox 
 .&amp;nbsp;Nitrous Oxide begins to separate out from entonox at about -6 degrees Celsius .&amp;nbsp;When this occurs entonox should not be used until it has been brought back to a useable temperature as per the guidance below. .&amp;nbsp;An homogenous mixture is again obtained when the temperature is raised to above 10 degrees Celsius and the cylinder is agitated&amp;nbsp; 
 &amp;nbsp; 
 Before use and to ensure it is properly mixed: 
 &amp;nbsp; 
 .&amp;nbsp;Cylinders should be stored horizontally for 24 hours at a temperature above 10 degrees. 
 .&amp;nbsp;If this is not practical, before use the cylinders must be mainta...</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154153</comments>
            <pubDate>Fri, 08 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3154153</guid>        </item>
        <item>
            <title>EMLA Cream 5% (Lidocaine 2.5% w/w Prilocaine 2.5% w/w) - Revised SPC</title>
            <link>http://www.medworm.com/index.php?rid=3108944&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FOther-Lib-Updates%2FSPC-Changes%2FEMLA-Cream-5-Lidocaine-25-ww-Prilocaine-25-ww---Revised-SPC%2F</link>
            <description>Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates &gt; SPC Changes
 Revised SPC includes changes to: 
 
 Section 4.8 (Undesirable Effects) -&amp;nbsp;&amp;nbsp;Undesirable effects are detailed in tables in order of system organ class and frequency.&amp;nbsp; Change to frequencies in adverse events. 
 Section 4.9 (Overdose) -&amp;nbsp;Rare cases of clinically significant methaemoglobinaemia have been reported. (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3108944</comments>
            <pubDate>Mon, 21 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3108944</guid>        </item>
        <item>
            <title>Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade</title>
            <link>http://www.medworm.com/index.php?rid=3102641&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDrug-Specific-Reviews%2FSugammadex-a-selective-reversal-medication-for-preventing-postoperative-residual-neuromuscular-blockade%2F</link>
            <description>Source: Cochrane Library
Area: Evidence &gt; Drug Specific Reviews
 Background Sugammadex is the first selective relaxant binding agent that has been studied for reversal of neuromuscular blockade induced by rocuronium and other steroidal non-depolarizing neuromuscular blocking agents (NMBAs). 
 &amp;nbsp; 
 Objectives To assess the efficacy and safety of sugammadex in reversing neuromuscular blockade induced by steroidal non-depolarizing NMBAs and in preventing postoperative residual neuromuscular blockade. 
 &amp;nbsp; 
 Search strategy We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2008, Issue 3), MEDLINE (1950 to August 2008), and EMBASE (1980 to August 2008). In addition, we handsearched reference lists of relevant articles and meeting abstracts. F...</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3102641</comments>
            <pubDate>Fri, 18 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3102641</guid>        </item>
        <item>
            <title>BMJ summary of NPSA safety report on avoiding midazolam overdose</title>
            <link>http://www.medworm.com/index.php?rid=3013575&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2009---November%2F20%2FBMJ-summary-of-NPSA-safety-report-on-avoiding-midazolam-overdose%2F</link>
            <description>Source: BMJ
Area: News
 This is the first in a series of BMJ summaries of recommendations to improve patients' safety, based on reports of safety concerns, incident analysis, and other evidence. The articles will highlight the risks of incidents that have the potential for serious harm and are not well known, and for which clear preventive actions are available. This summary is based on the safety report (rapid response report or RRR) from the NPSA in December 2008 on how to prevent overdose of midazolam. The RRR highlights evidence of harm and recommends key actions for staff. An accompanying article describes the process undertaken by the NPSA for developing rapid response reports, who to date have issued 22 RRRs. (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3013575</comments>
            <pubDate>Fri, 20 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3013575</guid>        </item>
        <item>
            <title>Lidocaine Hydrochloride Injection BP 1% w/v/, 2% w/v - Revised SPC</title>
            <link>http://www.medworm.com/index.php?rid=3005173&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FOther-Lib-Updates%2FSPC-Changes%2FLidocaine-Hydrochloride-Injection-BP-1-wv-2-wv---Revised-SPC%2F</link>
            <description>Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates &gt; SPC Changes
 Revised SPC includes changes to: 
 
 Section 4.2 (Posology and method of administration)&amp;nbsp;Addition of children's age - &quot;Single doses of Lidocaine (for anaesthesia other than spinal) should not exceed 4.5 mg/kg (or 200 mg) in adults or children 12 - 18 years of age.&quot; A further addition of:&amp;nbsp;&quot;Lidocaine by local infiltration for children under the age of 12 years should not exceed 3mg/kg, repeated not more often than every 4 hours.&quot; 
 Section 4.3 (Contraindications)&amp;nbsp;In ventricular arrhythmia:&amp;nbsp;Sino-atrial disorders, all grades of atrioventricular block,&amp;nbsp;severe myocardial depression, porphyria (use with caution in local anaesthesia). In local anaesthesia: complete heart block, hypovol...</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3005173</comments>
            <pubDate>Thu, 19 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3005173</guid>        </item>
        <item>
            <title>Launch of new sections for anaesthetics and critical care practitioners on MHRA website</title>
            <link>http://www.medworm.com/index.php?rid=2836921&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2009---September%2F28%2FLaunch-of-new-sections-for-anaesthetics-and-critical-care-practitioners-on-MHRA-website%2F</link>
            <description>Source: MHRA
Area: News
 The latest targeted healthcare professional group pages to be launched on the MHRA website are for anaesthetics care practitioners and for critical care practitioners. These pages aim to provide healthcare professionals with targeted information relevant to different specialities, and include guidance, safety alerts and links to educational material related to the safe use and management of medicines and medical devices. (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2836921</comments>
            <pubDate>Sun, 27 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2836921</guid>        </item>
        <item>
            <title>Xylocaine (lidocaine) 1% and 2% with Adrenaline - Revised SPC</title>
            <link>http://www.medworm.com/index.php?rid=2810547&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FOther-Lib-Updates%2FSPC-Changes%2FXylocaine-lidocaine-1-and-2-with-Adrenaline---Revised-SPC%2F</link>
            <description>Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates &gt; SPC Changes
 Section 4.3 (contraindications) has been updated and now reads as follows: 
 Hypersensitivity to local anaesthetics of the amide type, or to any of the excipients. 
 Hypersensitivity to methyl and/or propyl parahydroxybenzoate (methyl-/propyl paraben), or to their metabolite para amino benzoic acid (PABA). Formulations of lidocaine containing parabens should be avoided in patients allergic to ester local anaesthetics or their metabolite PABA. 
 The use of a vasoconstrictor is contra-indicated for anaesthesia of fingers, toes, tip of nose, ears and penis. 
 Information on drugs that reduce the clearance of lidocaine has been updated in section 4.5 (interactions) and now this paragraph now reads as follo...</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2810547</comments>
            <pubDate>Sat, 19 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2810547</guid>        </item>
        <item>
            <title>Neostigmine Methylsulphate Injection BP 2.5mg in 1ml (Hameln) - Revised SPC</title>
            <link>http://www.medworm.com/index.php?rid=2810546&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FOther-Lib-Updates%2FSPC-Changes%2FNeostigmine-Methylsulphate-Injection-BP-25mg-in-1ml-Hameln---Revised-SPC%2F</link>
            <description>Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates &gt; SPC Changes
 Section 4.3 (contraindications) has been updated.&amp;nbsp;The use of neostigmine with depolarising muscle relaxants is contraindicated.&amp;nbsp; 
 The following statement has been added to section 4.4 (special warnings and precautions for use): Administration of anticholinesterase agents to patients with intestinal anastomoses may produce rupture of the anastomosis or leakage of intestinal contents. (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2810546</comments>
            <pubDate>Sat, 19 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2810546</guid>        </item>
        <item>
            <title>Greater incidence of emergence agitation in children after sevoflurane anesthesia as compared with halothane: a meta-analysis of randomized controlled trials</title>
            <link>http://www.medworm.com/index.php?rid=2801822&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDrug-Class-Focused-Reviews%2FGreater-incidence-of-emergence-agitation-in-children-after-sevoflurane-anesthesia-as-compared-with-halothane-a-meta-analysis-of-randomized-controlled-trials%2F</link>
            <description>Source: DARE
Area: Evidence &gt; Drug Class Focused Reviews
 CRD Summary: This review assessed the incidence of emergence agitation in children anaesthetised with either sevoflurane or halothane. The authors concluded that sevoflurane exhibited a significantly greater incidence of emergence agitation. The authors' conclusions from this well-conducted review reflected the evidence presented and were likely to be reliable. 
 CRD Commentary: The review addressed a clear question and consulted a wide range of sources for studies with clear inclusion criteria. The literature search was restricted to publications in English and there was no apparent search for unpublished studies, so some studies may have been missed. Both publication and language bias could have been present, as acknowledged by th...</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2801822</comments>
            <pubDate>Wed, 16 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2801822</guid>        </item>
        <item>
            <title>Updated national IV monograph on propofol (Propofol-Lipuro 2%®)</title>
            <link>http://www.medworm.com/index.php?rid=2753550&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2009---September%2F02%2FUpdated-national-IV-monograph-on-propofol-Propofol-Lipuro-2%2F</link>
            <description>Source: Medusa
Area: News
 An updated IV monograph on propofol (Propofol-Lipuro 2%®) is now available from the NHS injectable medicines guide website (Medusa) at the link below (registration required for access). (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2753550</comments>
            <pubDate>Tue, 01 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2753550</guid>        </item>
        <item>
            <title>New national IV monograph on propofol (Propofol-Lipuro 1%®)</title>
            <link>http://www.medworm.com/index.php?rid=2753549&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2009---September%2F02%2FNew-national-IV-monograph-on-propofol-Propofol-Lipuro-1%2F</link>
            <description>Source: Medusa
Area: News
 A new IV monograph on propofol (Propofol-Lipuro 1%®) is now available from the NHS injectable medicines guide website (Medusa) at the link below (registration required for access). (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2753549</comments>
            <pubDate>Tue, 01 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2753549</guid>        </item>
        <item>
            <title>Local versus. general anaesthesia for carotid endarterectomy</title>
            <link>http://www.medworm.com/index.php?rid=2703232&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDisease-Focused-Reviews%2FLocal-versus-general-anaesthesia-for-carotid-endarterectomy%2F</link>
            <description>Source: Cochrane Library
Area: Evidence &gt; Disease Focused Reviews
 Background 
 Carotid endarterectomy reduces the risk of stroke in people with recently symptomatic, severe carotid artery stenosis. However, there are significant perioperative risks which may be lessened by performing the operation under local rather than general anaesthetic. This is an update of a Cochrane Review first published in 1996, and previously updated in 2008. 
 Objectives 
 To assess the risks of endarterectomy under local compared with general anaesthetic. 
 Search strategy 
 We searched the Cochrane Stroke Group Trials Register (last searched September 2008), MEDLINE (1966 to November 2008), EMBASE (1980 to November 2008) and Index to Scientific and Technical Proceedings (ISTP) (1980 to November 2008). We also...</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2703232</comments>
            <pubDate>Tue, 04 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2703232</guid>        </item>
        <item>
            <title>Xylocaine (lidocaine / adrenaline) 1% and 2% with Adrenaline - Revised SPC</title>
            <link>http://www.medworm.com/index.php?rid=2703233&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FOther-Lib-Updates%2FSPC-Changes%2FXylocaine-lidocaine--adrenaline-1-and-2-with-Adrenaline---Revised-SPC%2F</link>
            <description>Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates &gt; SPC Changes
 ??Section 4.3 (contraindications) now contains extra information regarding hypersensitivity to local anaesthetics of the amide type or to any of the excipients.  Section 4.5 (interactions) also now includes information on drugs that reduce the clearance of lidocaine. (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2703233</comments>
            <pubDate>Wed, 22 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2703233</guid>        </item>
        <item>
            <title>Etomidate or ketamine for emergency intubation?</title>
            <link>http://www.medworm.com/index.php?rid=2703234&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2009---July%2F01%2FEtomidate-or-ketamine-for-emergency-intubation%2F</link>
            <description>This study intended to compare outcomes between single doses of etomidate and ketamine in critically ill patients who required sedation for intubation. 
 &amp;nbsp; 
 Participants ... (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2703234</comments>
            <pubDate>Tue, 30 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2703234</guid>        </item>
        <item>
            <title>Hyoscine Injection BP 400mcg/ml - Revised SPC</title>
            <link>http://www.medworm.com/index.php?rid=2703236&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FOther-Lib-Updates%2FSPC-Changes%2FHyoscine-Injection-BP-400mcgml---Revised-SPC%2F</link>
            <description>Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates &gt; SPC Changes
 ?Section 4.8 (undesirable effects) has been updated with the&amp;nbsp;following side effects: dypsnoea, angiooedema, anaphalaxis and anaphalactic shock. (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2703236</comments>
            <pubDate>Sat, 20 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2703236</guid>        </item>
        <item>
            <title>Ketalar (ketamine) Injection - Revised SPC</title>
            <link>http://www.medworm.com/index.php?rid=2703235&amp;cid=s_38844_5_f&amp;fid=38844&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FOther-Lib-Updates%2FSPC-Changes%2FKetalar-ketamine-Injection---Revised-SPC%2F</link>
            <description>Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates &gt; SPC Changes
Section 4.3&amp;nbsp;(contra-indications) has been updated and now reads: 
 
 Ketalar is contra-indicated in persons in whom an elevation of blood pressure would constitute a serious hazard (see section 4.8 Undesirable effects). Ketamine hydrochloride is contraindicated in patients who have shown hypersensitivity to the drug or its components.&amp;nbsp; Ketalar should not be used in patients with eclampsia or pre-eclampsia, severe coronary or myocardial disease, cerebrovascular accident or cerebral trauma. 
 Section 4.4&amp;nbsp;(special warnings and special precautions for use) and&amp;nbsp;section 4.5 (interactions) have also been modified. (Source: NeLM - Anaesthesia)</description>
            <author>NeLM - Anaesthesia</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2703235</comments>
            <pubDate>Sat, 20 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2703235</guid>        </item>
    </channel>
</rss>

